Managing Disease and Treatment-Related Factors in RRMM

Managing Disease and Treatment-related Factors in Relapsed/Refractory Multiple Myeloma
Managing Disease and Treatment-related Factors in Relapsed/Refractory Multiple Myeloma
CME, CPE, CNE
Joshua Richter, MD; Robert Z. Orlowski, MD, PhD - Chair
Release Date: September 21, 2017
Expiration Date: September 21, 2018

In this interactive case activity, you will be challenged with making crucial therapeutic decisions that will affect your patient’s quality of life. Just as in the typical clinical setting, you’ll rely on test results, your assessments, and available guidelines to drive your decision-making. Think on your feet as adverse events arise, and learn valuable clinical guidance at key points along the way. Relapsed and refractory multiple myeloma poses a distinct set of challenges when it comes to selecting the appropriate treatment regimen and maintaining patient stability throughout disease progression. This activity will prepare you for those challenges.

Provided by The University of Texas MD Anderson Cancer Center and MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
Begin, Earn Credit